Search

everythinglearnresearchcommunity

for

Search:↓

The circadian clock is crucial for tissue renewal and regeneration, affecting stem cell functions and having implications for health and disease.

Growth factors are crucial for hair development and could help treat hair diseases.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Different types of stem cells exist within individual skin layers, and they can adapt to damage, transplantation, or tumor growth. These cells are regulated by their environment and genetic factors. Tumor growth is driven by expanding, genetically altered cells, not long-lived mutant stem cells. There's evidence of cancer stem cells in skin tumors. Other cells, bacteria, and genetic factors help maintain balance and contribute to disease progression. A method for growing mini organs from single cells has been developed.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Activating β-catenin in different skin stem cells causes various types of hair growth and skin tumors.

Found microRNA differences in hair cells, suggesting potential treatment targets for hair loss.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Some vitamin D analogs can thicken skin and reduce pore size like a common acne treatment, with one analog also affecting skin growth factors.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

Inhibiting Zyxin may help treat androgenetic alopecia by promoting hair growth.

Too much epidermal growth factor can cause hair loss.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Tyrosine kinases are important in skin autoimmune diseases and could be targets for new treatments.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Early intervention and tailored management can reduce skin side effects from cancer treatments.

Protein microarrays are highly sensitive tools useful for disease diagnosis and studying proteins.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

Advancements in nanoformulations for CRISPR-Cas9 genome editing can respond to specific triggers for controlled gene editing, showing promise in treating incurable diseases, but challenges like precision and system design complexity still need to be addressed.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The document concludes that stem cell inactivity is actively controlled and important for tissue repair and balance.

Sebaceous glands can heal and regenerate after injury using their own stem cells and help from hair follicle cells.

Normal skin cell renewal doesn't need RAR signaling, but vitamin A-related skin thickening does.

The document concludes that targeting the androgen receptor may be a promising breast cancer treatment, especially for certain types.

Genetic changes in mice help understand skin and hair disorders, aiding treatment development for acne and hair loss.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.